CG
VIVO

Colony Group’s Meridian Bioscience Inc VIVO Stock Holding History

Colony Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-147,902
Closed -$4.5M – 842
2022
Q2 		$4.5M Sell
147,902
-18,462
-11% -$499K 0.08% 215
2022
Q1 		$4.32M Buy
166,364
+838
+0.5% +$19.9K 0.06% 245
2021
Q4 		$3.38M Buy
165,526
+11,492
+7% +$220K 0.06% 264
2021
Q3 		$2.96M Buy
154,034
+5,250
+4% +$105K 0.06% 261
2021
Q2 		$3.3M Buy
148,784
+1,546
+1% +$32.8K 0.07% 230
2021
Q1 		$3.87M Buy
147,238
+14,372
+11% +$342K 0.08% 207
2020
Q4 		$2.48M Sell
132,866
-18,589
-12% -$347K 0.06% 252
2020
Q3 		$2.57M Buy
+151,455
New +$2.94M 0.07% 235

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Colony Group's VIVO Position: Q3 2022 in Review

Colony Group sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 147,902 shares — an estimated $4.5M sold.

Colony Group first reported a position in VIVO in Q3 2020 and held it in 8 quarters. The position peaked at $4.5M in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Colony Group reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Colony Group sold 147,902 Meridian Bioscience Inc shares in Q3 2022, an estimated $4.5M.
  • Colony Group first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 8 quarters.
  • Colony Group's Meridian Bioscience Inc position peaked at $4.5M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Colony Group's 13F filing for Q3 2022, filed 15 Nov 2022.